Merck Patent on Singulair Asthma Medicine Upheld (Update1) (Bloomberg)
Merck Patent on Singulair Asthma Medicine Upheld (Update1) (Bloomberg)
Aug. 19 (Bloomberg) — Merck & Co. s patent on the asthma treatment Singulair was upheld by a federal judge who said Teva Pharmaceutical Industries Ltd. can t make a copy of the medicine until the patent expires in 2012.